Key Points – Align Technology is shifting from standalone products to broader Invisalign “solutions,” including upgrades to its palatal expander and mandibular advancement offerings, while also developing capabilities to address both teeth and jaw/skeletal issues. – The company…
leaning into financing and active conversion initiatives, partnering with outside lenders like HFD and using DSO playbooks to make treatment more affordable and boost acceptance rates. – Growth remains stronger outside the U.S., with double-digit expansion across APAC, EMEA and Latin America, while North America stays challenged by weak consumer confidence and a split between fast-growing DSOs and slower independent practices. – Why These 3 Tech Stocks Could Be the Best Opportunities You’re Overlooking Align Technology (NASDAQ:ALGN) executives highlighted product innovation, financing initiatives and international expansion as key growth drivers during a discussion at the 2026 Stifel Jaws & Paws Conference. Chief Financial Officer John Morici, joined by Shirley Stacy, vice president of finance, global communications and investor relations, spoke with Stifel healthcare managing director Jonathan Block following a technology update the company held the prior day
Morici said Align is moving beyond individual products toward broader treatment “solutions,” including enhancements to its Invisalign Palatal Expander and mandibular advancement products. – Buy the Dip? These Earnings Misses Offer Long-Term Upside Morici said the company is adding features such as hooks and buttons to the palatal expander and developing products that can move teeth while also addressing jaw and skeletal issues. He said direct fabrication technology helps support that shift by making it easier for doctors to treat multiple issues at the same time, particularly in teenagers.
Financing and Conversion Initiatives Remain a Focus Morici said Align is also emphasizing “active conversion” strategies that it has learned…